Skip to main content
Loading

Advancing Gene Therapy Production: Overcoming PAT Challenges in Continuous Manufacturing

24 Jun 2025
Gene Therapy Manufacturing
  • Enhancing real-time monitoring and control to ensure product consistency and quality.
  • Navigating the complexities of scaling up continuous processes while meeting evolving regulatory expectations.
  • Tackling bottlenecks in vector production, purification, and formulation for cost-effective, high-quality gene therapies.
Industry Expert
Raj Dasari, Senior Director - Intellia Therapeutics